Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

REGN Regeneron Pharmaceuticals

Market Closed 04-24 16:00:00 EDT

751.57

-14.45

-1.89%

盘后750.00

-1.57-0.21%

19:57 EDT

High761.96	Low736.71	Vol809.55K
Open760.00	D1 Closing766.02	Amplitude3.30%
Mkt Cap79.46B	Tradable Cap77.64B	Total Shares105.72M
T/O605.77M	T/O Rate0.78%	Tradable Shares103.30M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":751.57,"timestamp":1777060800000,"preClose":766.02,"halted":0,"volume":809546,"hourTrading":{"tag":"盘后","latestPrice":750,"preClose":751.57,"latestTime":"19:57 EDT","volume":48957,"amount":36793205.4118,"timestamp":1777075043255,"change":-1.57,"changeRate":-0.002089,"amplitude":0.008476},"delay":0,"changeRate":-0.018863737239236483,"floatShares":103302739,"shares":105719806,"eps":41.59414,"marketStatus":"Market Closed","change":-14.45,"latestTime":"04-24 16:00:00 EDT","open":760,"high":761.955,"low":736.71,"amount":605769590.4726,"amplitude":0.032956,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":41.59414,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":766.02,"dividendRate":0.004887,"preHourTrading":{"tag":"盘前","latestPrice":760.38,"preClose":766.02,"latestTime":"09:29 EDT","volume":1412,"amount":1084592.58472,"timestamp":1777037341063,"change":-5.64,"changeRate":-0.007363,"amplitude":0.016188},"postHourTrading":{"tag":"盘后","latestPrice":750,"preClose":751.57,"latestTime":"19:57 EDT","volume":48957,"amount":36793205.4118,"timestamp":1777075043255,"change":-1.57,"changeRate":-0.002089,"amplitude":0.008476},"volumeRatio":1.14430135639526,"impliedVol":0.4564,"impliedVolPercentile":0.9084},"requestUrl":"/m/hq/s/REGN","defaultTab":"news","newsList":[{"id":"1137531425","title":"Earning Preview: Regeneron Pharmaceuticals this quarter’s revenue is expected to increase by 5.54%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1137531425","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1137531425?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:53","pubTimestamp":1776891219,"startTime":"0","endTime":"0","summary":"Abstract Regeneron Pharmaceuticals will report first-quarter 2026 results on April 29, 2026 Pre-Market, with consensus pointing to revenue of 3.46 billion US dollars and adjusted EPS of 8.77, while...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Regeneron Pharmaceuticals this quarter’s revenue is expected to increase by 5.54%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630227438","title":"Regeneron announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630227438","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630227438?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:11","pubTimestamp":1777061505,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals will hold its annual shareholder meeting online on June 12, 2026.Shareholders will vote on election of five directors to one-year terms.Investors will also cast advisory vote on compensation of named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regeneron Pharmaceuticals Inc. published the original content used to generate this news brief on April 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLRnkzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2106854487.HKD","LU0823434740.USD","LU0823434583.USD","LU0882574055.USD","LU1917777945.USD","BK4588","LU0320765992.SGD","LU0109394709.USD","LU0289739699.SGD","LU1974910355.USD","LU2237438978.USD","LU0889565916.HKD","LU0058720904.USD","LU0114720955.EUR","LU2362541273.HKD","LU2362540622.SGD","LU2362541513.USD","BK4139","LU2023250504.SGD","LU0823416689.USD","REGN","LU2089984988.USD","LU0053666078.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629727823","title":"Bernstein Adjusts Price Target on Regeneron Pharmaceuticals to $913 From $921, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2629727823","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629727823?lang=en_us&edition=fundamental","pubTime":"2026-04-24 23:21","pubTimestamp":1777044065,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $886.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resea","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629849996","title":"Canaccord Genuity Reaffirms Their Buy Rating on Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629849996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629849996?lang=en_us&edition=fundamental","pubTime":"2026-04-24 20:18","pubTimestamp":1777033128,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst John Newman maintained a Buy rating on Regeneron today and set a price target of $1,057.00. Newman covers the Healthcare ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-regeneron-regn-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-regeneron-regn-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629681794","title":"Is Regeneron Pharmaceuticals (REGN) Still Attractive After Recent Share Price Strength?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629681794","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629681794?lang=en_us&edition=fundamental","pubTime":"2026-04-24 17:06","pubTimestamp":1777021610,"startTime":"0","endTime":"0","summary":"If you are wondering whether Regeneron Pharmaceuticals at around US$766 per share still offers value, the answer depends on how you look at what the market is pricing in today.\nThe stock recently closed at US$766.02, with returns of 2.7% over 7 days, 3.3% over 30 days, a 1.3% decline year to date, and 28.4% over the last year, which gives you a mixed snapshot of recent sentiment.\nAlongside these moves, investors have been tracking broader sector developments and company specific updates that...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-regeneron-pharmaceuticals-regn-still-attractive-after-rec-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-regeneron-pharmaceuticals-regn-still-attractive-after-rec-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","BK4139","LU2362541513.USD","LU2023250504.SGD","LU0289739699.SGD","LU0058720904.USD","LU0823434740.USD","LU2106854487.HKD","LU0882574055.USD","BK4588","LU0114720955.EUR","LU1917777945.USD","LU0823434583.USD","LU0320765992.SGD","LU2362541273.HKD","REGN","LU0823416689.USD","BK4585","LU2362540622.SGD","DCF","LU2237438978.USD","LU2468319806.SGD","LU0889565916.HKD","LU1974910355.USD","LU2089984988.USD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629656088","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2629656088","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629656088?lang=en_us&edition=fundamental","pubTime":"2026-04-24 04:42","pubTimestamp":1776976920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  advanced 2.60% to $766.02 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.41% to 7,108.40 and Dow Jones Industrial Average  falling 0.36% to 49,310.32.The stock's rise snapped a three-day losing streak.Regeneron Pharmaceuticals Inc. closed 6.71% short of its 52-week high of $821.11, which the company achieved on January 9th.The stock outperformed some of its competitors Thursday, as Amgen Inc.  rose 0.78% to $348.62, Moderna Inc.  fell 4.95% to $52.85, and Gilead Sciences Inc.  rose 0.56% to $133.64.Trading volume  eclipsed its 50-day average volume of 652,714.Data source: Dow Jones Market Data, FactSet. Data compiled April 23, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629850826","title":"Regeneron Pharmaceuticals Shares Gain, Last up 2.5%; Announces Agreement With US Government to Help Lower Drug Costs for US Patients and Will Provide New Gene Therapy for Free in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2629850826","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629850826?lang=en_us&edition=fundamental","pubTime":"2026-04-24 03:50","pubTimestamp":1776973836,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nL1N4161DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023250504.SGD","LU2106854487.HKD","LU1917777945.USD","LU1974910355.USD","LU2468319806.SGD","BK4139","REGN","LU0823416689.USD","BK4588","LU0058720904.USD","BK4585","LU2089984988.USD","LU0823434740.USD","LU2362541513.USD","LU2362540622.SGD","LU0053666078.USD","LU0109394709.USD","LU0289739699.SGD","LU0823434583.USD","LU2237438978.USD","LU0889565916.HKD","LU2362541273.HKD","LU0320765992.SGD","LU0882574055.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629857748","title":"Regeneron wins three-year tariff relief under US Commerce agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2629857748","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629857748?lang=en_us&edition=fundamental","pubTime":"2026-04-24 03:46","pubTimestamp":1776973595,"startTime":"0","endTime":"0","summary":"Regeneron reached agreement with US government that includes three years of tariff relief under a Commerce Department deal.Deal removes future pricing mandates for Regeneron, tied to commitments to support US R&D and manufacturing.Regeneron will lower Medicaid prices based on pricing in other developed countries.US launch prices for future medicines will be aligned with prices set in that defined group of other countries.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL2FJgBb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","REGN","BK4588","LU1974910355.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","BK4585","LU0289739699.SGD","LU2089984988.USD","BK4139","IE00BKPKM429.USD","LU2468319806.SGD","LU2362541513.USD","LU0889565916.HKD","LU2095319765.USD","SG9999014013.SGD","LU0109394709.USD","SG9999014005.SGD","LU0114720955.EUR","NDAQ","LU0314104364.USD","LU0823434583.USD","IE00BGHQF748.EUR","BK4112","LU2210149790.SGD","LU0823434740.USD","IE00B64PRP62.GBP","LU2023250504.SGD","SG9999014021.USD","LU1917777945.USD","LU0823416689.USD","LU0320765992.SGD","LU2237438978.USD","LU2362541273.HKD","LU0053666078.USD","LU2106854487.HKD","LU0882574055.USD","LU2210150020.SGD","SG9999014039.USD","LU2362540622.SGD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629857784","title":"Regeneron Pharmaceuticals Inc - to Continue Large Investment in U.S. R&D and Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629857784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629857784?lang=en_us&edition=fundamental","pubTime":"2026-04-24 03:46","pubTimestamp":1776973576,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nTUA9H8WQL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823434740.USD","LU2089984988.USD","LU0109394709.USD","LU0053666078.USD","REGN","BK4139","LU2106854487.HKD","LU0114720955.EUR","LU0823416689.USD","LU2362541273.HKD","LU1974910355.USD","LU0889565916.HKD","LU0823434583.USD","BK4585","LU0320765992.SGD","LU0289739699.SGD","LU0058720904.USD","BK4588","LU2023250504.SGD","LU2362541513.USD","LU0882574055.USD","LU2468319806.SGD","LU2362540622.SGD","LU1917777945.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629857780","title":"Regeneron Pharmaceuticals Inc - Praluent to Be Available for Direct Patient Purchase Through Trumprx.gov","url":"https://stock-news.laohu8.com/highlight/detail?id=2629857780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629857780?lang=en_us&edition=fundamental","pubTime":"2026-04-24 03:46","pubTimestamp":1776973576,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nTUA9H8WQL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU2023250504.SGD","BK4585","LU1917777945.USD","LU0320765992.SGD","LU0823416689.USD","LU0823434740.USD","BK4588","LU2237438978.USD","LU0882574055.USD","LU0889565916.HKD","LU1974910355.USD","LU2362541273.HKD","LU0109394709.USD","BK4139","LU0289739699.SGD","LU0058720904.USD","LU0053666078.USD","LU0823434583.USD","REGN","LU2362541513.USD","LU2089984988.USD","LU2468319806.SGD","LU2106854487.HKD","LU2362540622.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629785778","title":"Regeneron Pharmaceuticals Inc - to Receive Three Years of Tariff Relief and Exemption From Future Pricing Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=2629785778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629785778?lang=en_us&edition=fundamental","pubTime":"2026-04-24 03:46","pubTimestamp":1776973576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nTUA9H8WQL:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4588","LU2023250504.SGD","LU2362541273.HKD","LU0109394709.USD","LU0058720904.USD","LU0114720955.EUR","LU0289739699.SGD","LU0053666078.USD","LU0823416689.USD","LU1917777945.USD","LU2362541513.USD","LU2106854487.HKD","LU0823434583.USD","LU2362540622.SGD","LU0823434740.USD","LU0889565916.HKD","LU2089984988.USD","REGN","LU2468319806.SGD","LU0882574055.USD","LU0320765992.SGD","LU2237438978.USD","BK4585","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629782857","title":"Regeneron Announces Agreement With U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629782857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629782857?lang=en_us&edition=fundamental","pubTime":"2026-04-24 03:46","pubTimestamp":1776973576,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nTUA9H8WQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","BK4139","LU0058720904.USD","LU0320765992.SGD","LU1974910355.USD","LU0823434740.USD","BK4588","LU0114720955.EUR","BK4585","LU0823416689.USD","LU0889565916.HKD","LU0882574055.USD","LU2468319806.SGD","LU0053666078.USD","LU2362540622.SGD","LU0823434583.USD","LU1917777945.USD","LU2237438978.USD","LU2362541273.HKD","LU0289739699.SGD","LU2023250504.SGD","LU2106854487.HKD","LU0109394709.USD","LU2362541513.USD","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629385773","title":"Regeneron Pharmaceuticals Inc - to Lower Medicaid Prices and Align Future U.S. Medicine Prices With Other Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2629385773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629385773?lang=en_us&edition=fundamental","pubTime":"2026-04-24 03:46","pubTimestamp":1776973576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nTUA9H8WQL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1974910355.USD","LU0320765992.SGD","LU2468319806.SGD","LU0053666078.USD","LU2237438978.USD","LU2106854487.HKD","LU0109394709.USD","LU0289739699.SGD","LU2023250504.SGD","LU1917777945.USD","LU2362541513.USD","LU0823434583.USD","BK4585","LU2089984988.USD","LU0058720904.USD","LU0823416689.USD","LU0114720955.EUR","LU2362540622.SGD","LU0889565916.HKD","LU0823434740.USD","LU2362541273.HKD","LU0882574055.USD","BK4139","BK4588","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629538857","title":"Regeneron to offer prescriptions at most favored nation prices, Trump says","url":"https://stock-news.laohu8.com/highlight/detail?id=2629538857","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629538857?lang=en_us&edition=fundamental","pubTime":"2026-04-24 03:13","pubTimestamp":1776971601,"startTime":"0","endTime":"0","summary":"Regeneron to offer prescriptions at most favored nation prices, Trump saysWASHINGTON, April 23  - U.S. President Donald Trump said on Thursday that Regeneron has agreed to offer prescriptions at most favored nation prices.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nS0N40Y03C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU0823434740.USD","LU0053666078.USD","LU1974910355.USD","LU0823416689.USD","LU2362541513.USD","LU2468319806.SGD","BK4585","LU0289739699.SGD","LU2237438978.USD","LU0823434583.USD","LU0114720955.EUR","BK4588","LU0882574055.USD","LU1917777945.USD","LU0320765992.SGD","LU2106854487.HKD","LU0058720904.USD","REGN","BK4139","LU2089984988.USD","LU2362540622.SGD","LU0889565916.HKD","LU2023250504.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629857553","title":"Trump: Regeneron Agreed to Lower Costs for Cholesterol Drug Praluent","url":"https://stock-news.laohu8.com/highlight/detail?id=2629857553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629857553?lang=en_us&edition=fundamental","pubTime":"2026-04-24 03:13","pubTimestamp":1776971598,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nS0N40Y03C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023250504.SGD","LU2106854487.HKD","LU1917777945.USD","LU1974910355.USD","LU2468319806.SGD","BK4139","REGN","LU0823416689.USD","BK4588","LU0058720904.USD","BK4585","LU2089984988.USD","LU0823434740.USD","LU2362541513.USD","LU2362540622.SGD","LU0053666078.USD","LU0109394709.USD","LU0289739699.SGD","LU0823434583.USD","LU2237438978.USD","LU0889565916.HKD","LU2362541273.HKD","LU0320765992.SGD","LU0882574055.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629573608","title":"Trump: Regeneron Agreed to Offer Prescriptions at Most Favored Nation Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2629573608","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629573608?lang=en_us&edition=fundamental","pubTime":"2026-04-24 03:13","pubTimestamp":1776971598,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nS0N40Y03C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU2106854487.HKD","LU0889565916.HKD","LU2237438978.USD","LU0109394709.USD","BK4585","LU2089984988.USD","LU0058720904.USD","LU0823434740.USD","LU0320765992.SGD","LU0289739699.SGD","LU2362541273.HKD","LU2362540622.SGD","LU2023250504.SGD","LU1917777945.USD","LU0823434583.USD","BK4139","LU0882574055.USD","LU0823416689.USD","LU1974910355.USD","REGN","LU0053666078.USD","LU2362541513.USD","LU2468319806.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629885444","title":"Sector Update: Health Care Stocks Lower in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2629885444","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629885444?lang=en_us&edition=fundamental","pubTime":"2026-04-24 01:56","pubTimestamp":1776966983,"startTime":"0","endTime":"0","summary":"Health care stocks declined Thursday afternoon, with the NYSE Health Care Index decreasing 0.5% and the State Street Health Care Select Sector SPDR ETF  shedding 0.7%.The iShares Biotechnology ETF  fell 1.9%.In sector news, Acting Attorney General Todd Blanche signed an order Thursday reclassifying state-licensed medical cannabis as a less-dangerous drug, the Associated Press reported, citing a statement from Blanche.In corporate news, Thermo Fisher Scientific  raised its full-year outlook as Q1 results came in stronger than expected, but organic growth fell short of analysts' estimates. Shares fell 11%.Regeneron Pharmaceuticals  has struck an agreement with the Trump administration to reduce drug costs for certain Americans and has secured approval for a gene therapy to treat a rare form of deafness, Bloomberg reported. Regeneron shares rose 1.6%.Novo Nordisk  said a phase 3a trial of oral semaglutide in children and adolescents aged between 10 and 17 years with type-2 diabetes showed","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2764262908.HKD","LU0061474960.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","LU2125910179.SGD","NVOX","LU2543165471.USD","LU2125909247.SGD","LU1854104046.USD","BK4534","LU2362541513.USD","IE00BKVL7J92.USD","LU0011850046.USD","LU0114720955.EUR","LU0122379950.USD","BK4588","IE00B2B36J28.USD","LU1623119135.USD","LU1670627923.USD","LU1917777945.USD","LU1153585028.USD","IE00B19Z8W00.USD","IE00BQXX3C00.GBP","LU1983299246.USD","REGN","BK4139","BK7104","BK4599","LU1988902786.USD","BK4548","IE0002141913.USD","LU1923621640.USD","LU1974910355.USD","XLV","BK4533","LU1280957306.USD","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2237438978.USD","IE00BQXX3F31.USD","LU1291159041.SGD","LU0096362180.USD","LU1023059063.AUD","LU2063271972.USD","LU1093756168.USD","LU1791710400.SGD","LU0345770308.USD","LU2106854487.HKD","LU1720051108.HKD","LU2092937221.SGD","LU2089984988.USD","NVO","IE0009355771.USD","LU2023250504.SGD","LU1061106388.HKD","LU0109394709.USD","LU2112291526.USD","IE00B19Z9505.USD","LU2362541273.HKD","NVOH","IE00B19Z8X17.USD","LU2720916845.USD","LABU","LU0823434740.USD","LU0053666078.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","BK4585","LU1064131342.USD","LU2360108059.USD","LU0208291251.USD","BK4121","BK4566","XBI","LU2125909759.SGD","GB00BDT5M118.USD","LU0557290698.USD","LU0957791311.USD","IE0034235188.USD","LU2211815571.USD","LU1633808545.USD","LU2433249047.HKD","LU2764263039.SGD","LU1923622291.USD","LU2362540622.SGD","LU1791710582.SGD","LU0889565916.HKD","LU0154236417.USD","LU0070302665.USD","LU0316494557.USD","LU2211814178.USD","IE00B4R5TH58.HKD","BK4535","LU0234572021.USD","LU1712237335.SGD","LU0266013472.USD","LU0345770993.USD","LU2041044095.USD","LU2125910336.SGD","IE00BZ1G4Q59.USD","IBB","LU2468319806.SGD","IE00BKPKM429.USD","LU2125909916.SGD","LU0823434583.USD","LU1803068623.USD","LU1670628061.USD","LU1093756325.SGD","LU0882574055.USD","LU2264538146.SGD","LU2764263203.CNY","LU1923622614.USD","TMO","BK4007","LU0320765992.SGD","IE00BQXX3D17.EUR","LU0528227936.USD","LU2125909593.SGD","LU0342679015.USD","LU0058720904.USD","LU0640476718.USD","BK4532","LU1854103824.USD","LU1548497426.USD","LU2357305700.SGD","LU1815333072.USD","LU1989771016.USD","LU2298321311.HKD","BK4581","LU0320765489.SGD","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629545438","title":"BUZZ-U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2629545438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629545438?lang=en_us&edition=fundamental","pubTime":"2026-04-24 01:44","pubTimestamp":1776966278,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Lululemon, United Rentals, cannabis stocks Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Cal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nL6N4160QV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBM","AAL","CRWD","RNA","NOW","AXP","REGN","ADBE","CRSH","QS","ADI","HLX","07766","NEE","LMT","ON","KDP","MBLY","ASGN","MSFT","LRCX","NFLX","ROP","LULU","MCHP","CMCSA","CSX","HELE","KREF","TSLA","INTU","LUCD","PCG","EFOR","TXN","NXPI","APLZ","HON","SIRI","WST","FCX","HAS","INTC","ALT","TMO","APLD","LULG","ELMT","AALG","PSKY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629851687","title":"FDA grants accelerated approval for Regeneron’s Otarmeni","url":"https://stock-news.laohu8.com/highlight/detail?id=2629851687","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629851687?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:45","pubTimestamp":1776962717,"startTime":"0","endTime":"0","summary":"Regeneron (REGN) Pharmaceuticals announced the U.S. Food and Drug Administration has granted accelerated approval for Otarmeni, the first gene ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-grants-accelerated-approval-for-regenerons-otarmeni-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-grants-accelerated-approval-for-regenerons-otarmeni-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2106854487.HKD","LABU","LU0823434740.USD","LU0823434583.USD","LU0882574055.USD","LU1917777945.USD","BK4588","LU0320765992.SGD","LU0109394709.USD","LU0289739699.SGD","LU1974910355.USD","LU2237438978.USD","LU0889565916.HKD","LU0058720904.USD","LU0114720955.EUR","LU2362541273.HKD","LU2362540622.SGD","LU2362541513.USD","BK4139","LU2023250504.SGD","LU0823416689.USD","REGN","LU2089984988.USD","LU0053666078.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629859794","title":"FDA grants accelerated approval to Regeneron gene therapy Otarmeni for OTOF hearing loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2629859794","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629859794?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:40","pubTimestamp":1776962426,"startTime":"0","endTime":"0","summary":"FDA granted accelerated approval to Regeneron gene therapy Otarmeni for severe-to-profound OTOF-related sensorineural hearing loss in pediatric and adult patients.Approval relied on CHORD trial week-24 results, with 80% of participants reaching hearing threshold ≤70 dB HL.Regeneron plans to provide Otarmeni free of charge in US, with administration costs potentially billed separately.Continued approval remains contingent on confirmatory evidence of clinical benefit in ongoing CHORD trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL8h07kK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU2210150020.SGD","BK4139","IE00BN0W2W23.USD","LU0058720904.USD","LU0320765992.SGD","LU1974910355.USD","LU0314104364.USD","LU0823434740.USD","BK4588","LU0114720955.EUR","BK4585","LU0823416689.USD","LU0889565916.HKD","LU0882574055.USD","LU2468319806.SGD","LU2210149790.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4112","LU0053666078.USD","LU2362540622.SGD","NDAQ","LU0823434583.USD","LU1917777945.USD","LU2237438978.USD","LU2362541273.HKD","IE00BKPKM429.USD","LU0289739699.SGD","IE00B64PRP62.GBP","LU2023250504.SGD","LU2106854487.HKD","SG9999014013.SGD","IE00B3QW5Z07.USD","LU0109394709.USD","LU2362541513.USD","IE00BN0W2T93.GBP","LU2095319765.USD","IE00BGHQF748.EUR","REGN","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regeneron.com","stockEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":0.0028},{"period":"3month","weight":-0.0026},{"period":"6month","weight":0.3004},{"period":"1year","weight":0.2531},{"period":"ytd","weight":-0.0263}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.514286,"avgChangeRate":0.03675},{"month":2,"riseRate":0.428571,"avgChangeRate":0.086855},{"month":3,"riseRate":0.457143,"avgChangeRate":-0.043382},{"month":4,"riseRate":0.457143,"avgChangeRate":0.015921},{"month":5,"riseRate":0.628571,"avgChangeRate":0.057479},{"month":6,"riseRate":0.428571,"avgChangeRate":0.006745},{"month":7,"riseRate":0.657143,"avgChangeRate":0.052646},{"month":8,"riseRate":0.542857,"avgChangeRate":0.022877},{"month":9,"riseRate":0.457143,"avgChangeRate":0.023281},{"month":10,"riseRate":0.4,"avgChangeRate":-0.00141},{"month":11,"riseRate":0.542857,"avgChangeRate":0.046018},{"month":12,"riseRate":0.485714,"avgChangeRate":0.043803}],"exchange":"NASDAQ","name":"Regeneron Pharmaceuticals","nameEN":"Regeneron Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Regeneron Pharmaceuticals(REGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Regeneron Pharmaceuticals,REGN,Regeneron Pharmaceuticals股票,Regeneron Pharmaceuticals股票老虎,Regeneron Pharmaceuticals股票老虎国际,Regeneron Pharmaceuticals行情,Regeneron Pharmaceuticals股票行情,Regeneron Pharmaceuticals股价,Regeneron Pharmaceuticals股市,Regeneron Pharmaceuticals股票价格,Regeneron Pharmaceuticals股票交易,Regeneron Pharmaceuticals股票购买,Regeneron Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regeneron Pharmaceuticals(REGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Regeneron Pharmaceuticals(REGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}